ADVERTISEMENT
ICICI Direct: Cipla Q2 Review - Strong Growth Across Segments
ICICI Direct: Cipla Q2 Review - Strong Growth Across Segments
09 Nov 2020, 08:21 AM IST 
An employee checks a vaccine vial moving along a vaccine vial monitor labeling machine at the Serum Institute of India Ltd. pharmaceutical plant in Pune (Photographer Sanjit Das/Bloomberg)
BQ Blue’s special research section collates qualityand in-depth equity and economy research reports from across India’s topbrokerages, asset managers and research agencies. These reports offerBloombergQuint’s subscribers an opportunity to expand their understanding ofcompanies, sectors and the economy.
I’m already a Subscriber Sign In
To continue reading this storySubscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
